SANOFI (1SAN.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1SAN • FR0000120578

81.9 EUR
+0.78 (+0.96%)
Last: Feb 4, 2026, 07:00 PM
Fundamental Rating

5

1SAN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. While 1SAN is still in line with the averages on profitability rating, there are concerns on its financial health. 1SAN is not valued too expensively and it also shows a decent growth rate. Finally 1SAN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year 1SAN was profitable.
  • Each year in the past 5 years 1SAN has been profitable.
  • Each year in the past 5 years 1SAN had a positive operating cash flow.
1SAN.MI Yearly Net Income VS EBIT VS OCF VS FCF1SAN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • 1SAN has a better Return On Assets (10.63%) than 72.73% of its industry peers.
  • 1SAN has a Return On Equity (18.84%) which is in line with its industry peers.
  • 1SAN has a Return On Invested Capital of 13.35%. This is in the better half of the industry: 1SAN outperforms 61.82% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1SAN is significantly below the industry average of 14.23%.
  • The last Return On Invested Capital (13.35%) for 1SAN is above the 3 year average (7.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROIC 13.35%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
1SAN.MI Yearly ROA, ROE, ROIC1SAN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • 1SAN's Profit Margin of 20.63% is fine compared to the rest of the industry. 1SAN outperforms 76.36% of its industry peers.
  • 1SAN's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 23.61%, 1SAN is in line with its industry, outperforming 52.73% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1SAN has grown nicely.
  • 1SAN's Gross Margin of 72.29% is in line compared to the rest of the industry. 1SAN outperforms 47.27% of its industry peers.
  • In the last couple of years the Gross Margin of 1SAN has remained more or less at the same level.
Industry RankSector Rank
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
1SAN.MI Yearly Profit, Operating, Gross Margins1SAN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • 1SAN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for 1SAN has been reduced compared to 1 year ago.
  • 1SAN has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, 1SAN has a worse debt to assets ratio.
1SAN.MI Yearly Shares Outstanding1SAN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
1SAN.MI Yearly Total Debt VS Total Assets1SAN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • A Debt/Equity ratio of 0.18 indicates that 1SAN is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.18, 1SAN is in the better half of the industry, outperforming 74.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.71
WACC7.8%
1SAN.MI Yearly LT Debt VS Equity VS FCF1SAN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that 1SAN should not have too much problems paying its short term obligations.
  • 1SAN has a Current ratio of 1.06. This is in the lower half of the industry: 1SAN underperforms 76.36% of its industry peers.
  • 1SAN has a Quick Ratio of 1.06. This is a bad value and indicates that 1SAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1SAN's Quick ratio of 0.30 is on the low side compared to the rest of the industry. 1SAN is outperformed by 92.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.3
1SAN.MI Yearly Current Assets VS Current Liabilites1SAN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • 1SAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.39%.
  • The Earnings Per Share has been growing slightly by 3.37% on average over the past years.
  • 1SAN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.49%.
  • The Revenue has been growing slightly by 4.57% on average over the past years.
EPS 1Y (TTM)-8.39%
EPS 3Y-5.17%
EPS 5Y3.37%
EPS Q2Q%-43.11%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%4.2%

3.2 Future

  • 1SAN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.19% yearly.
  • Based on estimates for the next years, 1SAN will show a small growth in Revenue. The Revenue will grow by 5.52% on average per year.
EPS Next Y20.15%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
EPS Next 5Y11.19%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y5.52%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1SAN.MI Yearly Revenue VS Estimates1SAN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
1SAN.MI Yearly EPS VS Estimates1SAN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.63, which indicates a very decent valuation of 1SAN.
  • Based on the Price/Earnings ratio, 1SAN is valued cheaply inside the industry as 83.64% of the companies are valued more expensively.
  • 1SAN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.67.
  • A Price/Forward Earnings ratio of 9.69 indicates a reasonable valuation of 1SAN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1SAN indicates a rather cheap valuation: 1SAN is cheaper than 83.64% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.20. 1SAN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.63
Fwd PE 9.69
1SAN.MI Price Earnings VS Forward Price Earnings1SAN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1SAN.MI Per share data1SAN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • 1SAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of 1SAN may justify a higher PE ratio.
  • 1SAN's earnings are expected to grow with 12.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)3.45
EPS Next 2Y12.73%
EPS Next 3Y12.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. Dividend

5.1 Amount

  • 1SAN has a Yearly Dividend Yield of 5.35%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.95, 1SAN pays a better dividend. On top of this 1SAN pays more dividend than 90.91% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, 1SAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.35%

5.2 History

  • The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1SAN pays out 34.36% of its income as dividend. This is a sustainable payout ratio.
  • 1SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.36%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
1SAN.MI Yearly Income VS Free CF VS Dividend1SAN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
1SAN.MI Dividend Payout.1SAN.MI Dividend Payout, showing the Payout Ratio.1SAN.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SANOFI

BIT:1SAN (2/4/2026, 7:00:00 PM)

81.9

+0.78 (+0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap197.81B
Revenue(TTM)46.72B
Net Income(TTM)13.80B
Analysts79.31
Price Target101.29 (23.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.35%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-3.88%
PT rev (3m)-5.05%
EPS NQ rev (1m)2.75%
EPS NQ rev (3m)-0.03%
EPS NY rev (1m)-0.59%
EPS NY rev (3m)-2.58%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)0.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE 11.63
Fwd PE 9.69
P/S 2.96
P/FCF N/A
P/OCF N/A
P/B 2.7
P/tB 45
EV/EBITDA N/A
EPS(TTM)7.04
EY8.6%
EPS(NY)8.45
Fwd EY10.32%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.7
BVpS30.33
TBVpS1.82
PEG (NY)0.58
PEG (5Y)3.45
Graham Number69.32
Profitability
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROCE 16.17%
ROIC 13.35%
ROICexc 14.69%
ROICexgc 65.49%
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
FCFM N/A
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-ScoreN/A
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.3
Altman-Z N/A
F-ScoreN/A
WACC7.8%
ROIC/WACC1.71
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.39%
EPS 3Y-5.17%
EPS 5Y3.37%
EPS Q2Q%-43.11%
EPS Next Y20.15%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
EPS Next 5Y11.19%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%4.2%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y5.52%
EBIT growth 1Y9.12%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.46%
EBIT Next 3Y13.63%
EBIT Next 5Y10.94%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI / 1SAN.MI FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to 1SAN.MI.


What is the valuation status of SANOFI (1SAN.MI) stock?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI (1SAN.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for SANOFI?

SANOFI (1SAN.MI) has a profitability rating of 6 / 10.


How financially healthy is SANOFI?

The financial health rating of SANOFI (1SAN.MI) is 3 / 10.


What is the expected EPS growth for SANOFI (1SAN.MI) stock?

The Earnings per Share (EPS) of SANOFI (1SAN.MI) is expected to grow by 20.15% in the next year.